Using the nervous system to change medicine
Thync is a bioelectronics company developing pioneering treatments for autoimmune disorders and mental health.
Our non-invasive, bioelectronic platform effectively targets autonomic nerve pathways important in a number of disease processes while providing superior safety relative to pharmaceutical interventions.
We are focused on Psoriasis as our lead indication and are conducting clinical studies to pursue FDA Clearance and establish the first bioelectronic therapy in Psoriasis.
Scientific Research and Usage
Thync’s core technology for non-invasively modulating the autonomic nervous system was developed by a team of neuroscientists from MIT, Harvard, & Stanford. It has been extensively tested and used in the consumer health market and subsequently enhanced to become a therapeutic platform.